The Division of Experimental Hematology formed part of a multi-center consortium that successfully applied for a three year funding program from the DFG, to study aging-associated epigenetic as a therapeutic target in acute myeloid leukemia. The Division’s role in the Forschergruppe will be to investigate epigenetic remodelling and clonal selection in a murine model of accelerated hematopoietic stem cell aging, and will be carried out in collaboration with Dr. Daniel Lipka from the Divison of Epigenomics and Cancer Risk Factors.

The Division of Experimental Hematology has been awarded project funding as part of a Helmholtz Association-wide call for funding on future topics relating to health. The consortium is focussed on the topic of Ageing and Metabolic Programming (AMPro) and the funding period will run for three years.

The Division of Experimental Hematology, has just been awarded a four year project grant as part of the third renewal of the SFB873 Collaborative Research Centre on Stem Cell Biology. The funding mechanism from the DFG, supports a Heidelberg-based consortium focussed on studying the maintenance and differentiation of stem cells in development and disease. The project grant is a direct collaboration between the Division of Experimental Hematology and the Stress-Induced Activation of Hematopoietic Stem Cells Research Group, headed by Dr. Marieke Essers, which will start in July 2018.

  1. Renewal of project funding from the Fritz Thyssen Stiftung
  2. Project grant from the Deutsche Krebshilfe
  3. Sina Stäble awarded the DKFZ/Weizmann Institute Fellowship
  4. Ruzhica Bogeska to present at Basel Stem Cell Network
  5. Travel Award to Julius Gräsel